FT writers discuss maternal and child health on Twitter

Concerns about funding came on top of the list in an FT Twitter chat about Maternal and Child Health. The conversation took place during World Prematurity Day on November 1...

Powerful new technique reveals the mechanical environment of cells in their natural habitat, the living embryo

Whether building organs or maintaining healthy adult tissues, cells use biochemical and mechanical cues from their environment to make important decisions, such as becoming...

“I Am Deaf & I Love to Dance!”- Inclusive Dance Festival Offers a Platform to the Disabled

The idea behind Tandav is as profound as it is simple. Tandav was started by brothers Vishnu and Vishal Soman in 2014, with the aim of celebrating dance with people from al...

Vivek Oberoi's web series in Marathi is all about how to make the impossible possible.

Vivek Oberoi’s nine-episode web series in Marathi is all about how to make the impossible possible

Actor-producer Vivek Oberoi is developing a nine-epis...

Socially-conscious children’s films use artistic platform to educate

Hollywood has always been criticized for trying to engineer American society. For example, MSNBC’s Joe Scarborough accused Brokeback Mountain of advancing a “ra...

More young people are watching Planet Earth 2 than The X Factor

It seems the nation’s younger citizens are finally favouring the beauty of the natural world over the wailing of amateur singers.

The BBC has confirmed ...

Udayer Pathe - A Star Is Born

With Udayer Pathe, a new star was born – the name was BIMAL ROY.
As cinematographer, that star quality was evident after he shot P.C .Barua’s MUKTI. Deser...

'You Can't Stand by and Watch People Die': The Woman Developing an HIV Vaccine

In the 1990s, Dr. Glenda Gray was an activist and medical student, fighting to end segregation in the hospitals of apartheid South Africa and mobilize communities around he...

New, Genetically-Modified HIV Vaccine Enters Next Phase of Trials

A new possible HIV vaccine that uses a genetically-modified version of the virus is heading into Phase II trials. The results of an earlier trial showed it provoked an immu...